Exclusive: CureVac becomes second company to test coronavirus vaccine in Germany - sources
The unlisted biotech firm CureVac will become the second company to launch human trials of an experimental coronavirus vaccine in Germany, two people familiar with the plans told Reuters on Tuesday. [Source]
Publication Date:Origin: reuters.com
Category: healthNews
Topics: Germany, vaccine, coronavirus, company, second, CureVac, Reuters, plans, familiar, people, experimental, trials, human, launch, become, biotech, unlisted, sources, becomes, Exclusive